Cargando…

(−)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions

(−)-Epigallocatechin gallate (EGCG) exerts multiple beneficial effects on cardiovascular performance. In this study, we aimed to examine the effects of EGCG on diabetic cardiomyopathy during myocardial ischemia/reperfusion (I/R) injury. EGCG (100 mg/kg/day) was administered at week 6 for 2 weeks to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yang, Xia, Zhong-Yuan, Zhao, Bo, Leng, Yan, Dou, Juan, Meng, Qing-Tao, Lei, Shao-Qing, Chen, Zhi-Ze, Zhu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504977/ https://www.ncbi.nlm.nih.gov/pubmed/28714516 http://dx.doi.org/10.3892/ijmm.2017.3014

Ejemplares similares

Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts
por: Salameh, Aida, et al.
Publicado: (2018)

Cardioprotective effect of epigallocatechin gallate in myocardial ischemia/reperfusion injury and myocardial infarction: a meta-analysis in preclinical animal studies
por: Wei, Xin-Yu, et al.
Publicado: (2023)

Polyphenol (-)-epigallocatechin gallate-induced cardioprotection may attenuate ischemia-reperfusion injury through adenosine receptor activation: a preliminary study
por: Lee, Sang Kwon, et al.
Publicado: (2012)

Polyphenol (-)-epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function
por: Kim, Chan Jin, et al.
Publicado: (2010)

Epigallocatechin-3-Gallate Attenuates Myocardial Dysfunction via Inhibition of Endothelial-to-Mesenchymal Transition
por: Kim, Sejin, et al.
Publicado: (2023)

Curcumin attenuates myocardial ischemia–reperfusion injury
por: Liu, Kun, et al.
Publicado: (2017)

Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia–reperfusion injury in rats
por: Lv, Jun, et al.
Publicado: (2015)

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats
por: ZHONG, WEI, et al.
Publicado: (2015)

Glycine attenuates myocardial ischemia-reperfusion injury by inhibiting myocardial apoptosis in rats
por: Zhong, Xiaozheng, et al.
Publicado: (2012)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis
por: Yue, Lin, et al.
Publicado: (2022)

Epigallocatechin 3-Gallate Has a Neuroprotective Effect in Retinas of Rabbits with Ischemia/Reperfusion through the Activation of Nrf2/HO-1
por: Rivera-Pérez, Josué, et al.
Publicado: (2020)

(-)-Epigallocatechin-3-gallate promotes intestinal epithelial proliferation and barrier function after ischemia/reperfusion injury via activation of Nurr1
por: Gao, Jiacheng, et al.
Publicado: (2023)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats
por: PARK, Dong-Ju, et al.
Publicado: (2020)

Amifostine Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress
por: Wu, Shao-ze, et al.
Publicado: (2017)

Inhibition of ALDH2 by O-GlcNAcylation contributes to the hyperglycemic exacerbation of myocardial ischemia/reperfusion injury
por: Liu, Baoshan, et al.
Publicado: (2016)

Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells
por: Lee, Myung-Yul, et al.
Publicado: (2013)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Exosomes Derived From Epigallocatechin Gallate-Treated Cardiomyocytes Attenuated Acute Myocardial Infarction by Modulating MicroRNA-30a
por: Zhang, Chan, et al.
Publicado: (2020)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice
por: Kitazume-Taneike, Rika, et al.
Publicado: (2019)

Neuroprotective Activity of (−)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
por: Liu, Jin-Biao, et al.
Publicado: (2016)

Selenium inhibits ferroptosis in hyperglycemic cerebral ischemia/reperfusion injury by stimulating the Hippo pathway
por: Li, Lu, et al.
Publicado: (2023)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020)

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
por: Cui, Yue, et al.
Publicado: (2021)

Attenuation of muscle wasting in murine C(2)C(12) myotubes by epigallocatechin-3-gallate
por: Mirza, Kamran A., et al.
Publicado: (2014)

(−)-Epigallocatechin Gallate Targets Notch to Attenuate the Inflammatory Response in the Immediate Early Stage in Human Macrophages
por: Wang, Tengfei, et al.
Publicado: (2017)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate
por: Zeng, Jiajun, et al.
Publicado: (2018)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d0nssjlrbv476md67ikou7j59v